CNBC ETF Edge: Biotech Getting Sick?

Reviewed by: etf.com

Edited by: etf.com

This new show features special guests Ben Johnson of Morningstar and Dave Nadig of ETF.com.

CNBC's ETF Edge is dedicated to the fastest-growing trend in investing right now: ETFs. Every Monday, Bob Pisani is joined by a panel of top market participants at the NYSE to offer educational and actionable advice to help you build your best portfolio.

How you should trade the biotech ETFs from CNBC.

etf.com

etf.com is the single source for ETF intelligence. We provide real-time ETF news and analysis to educate investors and drive financial knowledge in the space. Our personalized and accurate information, alongside industry-leading financial tools, are depended upon to develop winning investment and financial decisions. At etf.com, we strive to serve both the individual investor as well as the professional financial advisor to educate and grow the ETF community.

View Bio Follow Author

CNBC ETF Edge: Biotech Getting Sick?

CNBC ETF Edge: Biotech Getting Sick?

Related Stories

Related Topics

More From etf.com

Related Media